<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11761">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02122406</url>
  </required_header>
  <id_info>
    <org_study_id>31748\2009 progetto lorhen</org_study_id>
    <nct_id>NCT02122406</nct_id>
  </id_info>
  <brief_title>Depression and Anxiety in Rheumatoid Arthritis</brief_title>
  <acronym>DEAR</acronym>
  <official_title>Depression and Anxiety in Rheumatoid Arthritis: Prevalence and Relation With Disease Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary endpoint of this study is to evaluate the prevalence of anxiety and depressive
      disorders, and their relationship with disease activity, in patients with rheumatoid
      arthritis treated with biological drugs
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Disease Activity Score 28</measure>
    <time_frame>1 day of enrollement</time_frame>
    <safety_issue>No</safety_issue>
    <description>Disease Activity Score base on 28 joint count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>1 day of enrollement</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hospital Anxiety and Depression Scale (HADS) questionnaire</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Patients RA-BIO</arm_group_label>
    <description>Patients with rheumatoid arthritis treated with biological drugs</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with rheumatoid arthritis currently treated with biological drugs.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;18 years

          -  diagnosis of rheumatoid arthritis according to 2010  Classification American College
             of Rheumatology/ European League Against Rheumatism (ACR/EULAR)   Criteria

          -  being able to compile questionnaire

          -  current treatment with biological disease-modifying antirheumatic drug

        Exclusion Criteria:

          -  Current treatment for anxiety or depressive disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto Caporali, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Pavia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vittorio Grosso, MD</last_name>
    <phone>+393332605945</phone>
    <email>vittorio.grosso@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS policlinico San Matteo - Reparto di Reumatologia</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Caporali, MD</last_name>
      <phone>0382502419</phone>
      <email>ic.specmed@smatteo.pv.it</email>
    </contact>
    <investigator>
      <last_name>Vittorio Grosso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>April 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Vittorio Grosso</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <keyword>DAS28</keyword>
  <keyword>HADS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
